🇺🇸 FDA
Pipeline program

Placebo Rosuvastatin Calcium 20 mg tablets, ROSUVASTATIN CALCIUM

CTO # 2095

Phase 3 small_molecule active

Quick answer

Placebo Rosuvastatin Calcium 20 mg tablets, ROSUVASTATIN CALCIUM for Venous thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Venous thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials